Payam Nahid
Executive Director · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
- 1998–2001
Scripps Clinic & Research Foundation
Research
Clinical Infectious Diseases · 2016 · First of 27 authors · 908 citations
Advances in the development of new tuberculosis drugs and treatment regimens
Review · Nature Reviews Drug Discovery · 2013 · 659 citations
Towards tuberculosis elimination: an action framework for low-incidence countries
European Respiratory Journal · 2015 · 616 citations
48 papers · 2 as a fellow
- CD
32 papers
22 papers
22 papers
21 papers
18 papers
- MW
16 papers
- AV
15 papers
Grants
- 2026–2031
Facilitating Accelerated Science and Translation for TB Regimen Development (FAST-TB)
National Institute of Allergy and Infectious Diseases · R24
Contact PI · $3.5M · University of California, San Francisco
- 2025–2030
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $10.1M · University of California, San Francisco
- 2020–2030
Tuberculosis Research and Mentorship Program (TB RAMP II)
National Institute of Allergy and Infectious Diseases · R25
Contact PI · $2.8M · University of California, San Francisco
- 2020–2027
C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $19.3M · University of California, San Francisco
Clinical trials
- 2022–2027
Principal investigator · Active not recruiting · Phase 2
Boston University
- 2016–2021
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Study chair · Completed · Phase 3
Centers for Disease Control and Prevention